Massachusetts Courts Limits D&O Coverage
A federal district court has ruled in Genzyme Corp. v. Federal Ins. Co., No. 08CV10988 (D. Mass. September 28, 2009) that a shareholder class action in which the plaintiffs alleged that Genzyme’s directors and officers had schemed to depress the market value of a subsidiary so that it could fold it into the corporation in a manner favorable to other shareholders failed to trigger coverage under a Directors & Officers policy.
Judge Gertner ruled that the sums that Genzyme had paid to settle these claims were not an insurable loss both because the policy should not insure directors and officers for being forced to disgorge monies to which they were not entitled and by reasons of public policy.
The District Court distinguished cases in which other courts had refused to find coverage for restitution, archly observing that in this case, “Genzyme was less a Butch Cassidy than a Robin Hood as its thefts were for the benefit of others, not for itself.” The court ruled that, “Genzyme should not be able to divide the benefits of equity ownership among its shareholders one way, redistribute those benefits, and then demand indemnification from its insurer for the re-division.”
In any event, the court ruled that these claims were subject to a “bump up” provision in the Federal policy which stated that there was no coverage for that part of loss arising out of any payment of “allegedly inadequate consideration in connection with [the insured’s] purchase of securities issued by any insured organization.”
